SPDR S&P Pharmaceuticals ETF Rating $38.42 +0.81 (+2.15%) Closing price 04/17/2025 04:10 PM EasternExtended Trading$38.24 -0.19 (-0.48%) As of 04/17/2025 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.71Holdings in XPH have an aggregate rating of Moderate Buy based on 362 analyst ratings issued in the past year covering 42 companies (99.9% of the portfolio).XPH Aggregate Price Target$38.42High Prediction$38.42Average Prediction$38.42Low Prediction$38.42Holdings in XPH have an aggregate price target of $38.42 and a range of $38.42 to $38.42 covering 42 companies (99.9% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.09%CORTCorcept Therapeutics$62.24-3.7%4.4072 of 5 stars3.00$143.25 130.2%5Positive News4.32%TARSTarsus Pharmaceuticals$49.25-0.3%2.8812 of 5 stars3.00$63.67 29.3%7News CoveragePositive News4.25%RPRXRoyalty Pharma$32.51+1.0%4.5115 of 5 stars3.00$42.50 30.7%5News CoveragePositive News4.10%JNJJohnson & Johnson$157.42+2.3%4.5043 of 5 stars2.56$171.82 9.1%18Earnings ReportDividend IncreaseAnalyst ForecastOptions VolumeAnalyst RevisionNews Coverage3.97%PRGOPerrigo$25.35+0.8%4.8522 of 5 stars2.25$33.00 30.2%4News CoveragePositive News3.94%ZTSZoetis$148.64+1.3%4.5789 of 5 stars3.08$214.40 44.2%12News CoveragePositive News3.94%PBHPrestige Consumer Healthcare$80.10+0.4%4.1678 of 5 stars2.50$93.33 16.5%6Positive News3.88%LLYEli Lilly and Company$841.70+14.5%4.7942 of 5 stars2.89$1,012.00 20.2%19News CoveragePositive NewsGap UpHigh Trading Volume3.79%AXSMAxsome Therapeutics$104.460.0%4.5797 of 5 stars3.00$169.80 62.6%16Analyst RevisionPositive News3.72%PFEPfizer$22.13+0.4%4.9986 of 5 stars2.59$31.07 40.4%173.58%BMYBristol-Myers Squibb$49.24-0.3%4.729 of 5 stars2.32$57.67 17.1%19Upcoming EarningsShort Interest ↓Analyst RevisionNews CoveragePositive News3.55%MRKMerck & Co., Inc.$77.93+1.9%4.9993 of 5 stars2.64$115.50 48.2%22Upcoming EarningsAnalyst ForecastPositive News3.47%VTRSViatris$7.56+2.3%2.8645 of 5 stars1.75$10.50 38.9%4News Coverage3.38%ELANElanco Animal Health$8.44+4.2%4.3522 of 5 stars2.43$14.67 73.7%7News Coverage3.29%PCRXPacira BioSciences$24.65+0.7%2.12 of 5 stars2.33$26.67 8.2%93.28%JAZZJazz Pharmaceuticals$102.78+1.2%4.8891 of 5 stars2.93$187.71 82.6%14News CoveragePositive News3.13%OGNOrganon & Co.$11.11+2.7%4.8442 of 5 stars2.43$20.60 85.5%7Short Interest ↓News CoveragePositive News2.81%HRMYHarmony Biosciences$28.46+1.9%4.558 of 5 stars3.00$53.33 87.4%9Short Interest ↓Positive News2.56%ARVNArvinas$8.60+12.4%3.6239 of 5 stars2.69$34.33 299.2%16Analyst ForecastShort Interest ↓News CoveragePositive NewsHigh Trading Volume2.49%AMPHAmphastar Pharmaceuticals$23.35+1.6%4.2827 of 5 stars2.00$43.50 86.3%3News CoveragePositive News2.32%ANIPANI Pharmaceuticals$69.21+0.0%3.6227 of 5 stars3.00$79.75 15.2%9Analyst UpgradeNews Coverage2.22%SUPNSupernus Pharmaceuticals$30.76+0.2%2.9519 of 5 stars2.33$36.00 17.0%3Analyst UpgradeNews Coverage2.12%EWTXEdgewise Therapeutics$13.41+2.9%2.2761 of 5 stars2.75$40.38 201.2%8Gap Up1.93%LGNDLigand Pharmaceuticals$104.97+0.3%4.3204 of 5 stars3.00$146.43 39.5%7Analyst UpgradeNews CoveragePositive News1.86%HROWHarrow$23.99+2.7%2.6793 of 5 stars3.00$60.50 152.2%4Positive NewsGap Up1.83%COLLCollegium Pharmaceutical$27.010.0%4.096 of 5 stars2.80$43.60 61.4%5Analyst DowngradePositive News1.79%LQDALiquidia$13.72+0.3%2.2558 of 5 stars3.11$26.63 94.1%9Insider TradeNews Coverage1.70%INVAInnoviva$18.27+1.0%4.2514 of 5 stars3.00$55.00 201.0%2Positive News1.33%AMRXAmneal Pharmaceuticals$7.36+2.5%3.2186 of 5 stars3.00$10.80 46.7%5Short Interest ↑News CoveragePositive NewsGap Up1.06%OCULOcular Therapeutix$7.31+2.0%3.4814 of 5 stars2.89$16.38 124.0%9Positive News1.02%WVEWave Life Sciences$5.92+1.4%4.1832 of 5 stars3.00$22.18 274.7%11Short Interest ↑News Coverage1.00%MNMDMind Medicine (MindMed)$5.77+5.7%2.2938 of 5 stars3.23$25.11 335.2%13Analyst RevisionNews Coverage0.99%EOLSEvolus$10.79+6.7%3.5031 of 5 stars3.00$23.75 120.1%5Analyst ForecastNews CoverageGap Up0.97%CRMDCorMedix$7.67+2.0%2.8848 of 5 stars3.14$14.50 89.0%70.81%XERSXeris Biopharma$4.11+0.7%4.229 of 5 stars2.80$6.10 48.4%5Short Interest ↑News CoveragePositive News0.79%NUVBNuvation Bio$1.97+4.5%2.5112 of 5 stars3.25$8.75 345.3%4Positive News0.79%OMEROmeros$6.78+0.3%3.7674 of 5 stars2.80$22.50 231.9%5Gap Up0.71%EYPTEyePoint Pharmaceuticals$5.68+2.3%1.4819 of 5 stars3.00$26.63 368.8%9Positive NewsGap Up0.58%ELVNEnliven Therapeutics$16.53+2.9%2.7257 of 5 stars3.25$40.33 144.0%4Positive News0.52%ESPREsperion Therapeutics$0.95-1.4%3.8063 of 5 stars2.50$6.42 575.4%6Analyst ForecastNews CoveragePositive News0.49%ZVRAZevra Therapeutics$7.15+1.4%2.642 of 5 stars3.11$22.29 211.7%9News CoveragePositive News0.48%PAHCPhibro Animal Health$17.29+2.7%3.94 of 5 stars1.50$19.75 14.2%4Analyst ForecastNews CoveragePositive News This page (NYSEARCA:XPH) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
